Myasthenia Gravis

Alexion Seeking New Indication for Myasthenia Gravis Drug

Alexion Seeking New Indication for Myasthenia Gravis Drug

By

Soliris is currently approved to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Rituximab Offers Hope for Refractory Myasthenia Gravis

Rituximab Offers Hope for Refractory Myasthenia Gravis

By

Sixty-three percent of patients achieved a complete and stable response that allowed them to discontinue all immunotherapies.

Thymectomy Helps Improve Strength in Myasthenia Gravis

Thymectomy Helps Improve Strength in Myasthenia Gravis

By

Patients who underwent surgery also experienced lower distress levels from treatment-related symptoms.

Consensus Guidelines for the Treatment of Myasthenia Gravis

Consensus Guidelines for the Treatment of Myasthenia Gravis

By

The guidelines are the result of a consensus of an international task force of MG experts.

Stem Cell Transplant May Promote Remission in Myasthenia Gravis

Stem Cell Transplant May Promote Remission in Myasthenia Gravis

Treatment has been linked to durable, symptom-free, treatment-free remission in several cases of MG.

Sign Up for Free e-newsletters